TY  - JOUR
AU  - Dujmović, Irena
AU  - Pekmezović, Tatjana D
AU  - Obrenović, Radmila Z
AU  - Nikolić, Aleksandra L.
AU  - Spasić, Mihajlo
AU  - Mostarica-Stojković, Marija B
AU  - Drulović, Jelena S
PY  - 2009
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/1442
AB  - Background: Peroxynitrite was hypothesized to be involved in the pathogenesis of multiple sclerosis (MS) through its various neurotoxic effects. Uric acid (UA) was shown to be a strong peroxynitrite scavenger. Methods: We analyzed cerebrospinal fluid (CSF) and serum UA concentrations in 30 MS patients and 20 controls with non-inflammatory neurological diseases (NIND) and correlated these findings with demographic and clinical characteristics of MS patients. Disease activity was assessed by brain magnetic resonance imaging (MRI) and the CSF/serum albumin quotient as an indicator of the state of blood-brain-barrier (BBB). Results: Serum UA concentrations were found to be significantly lower in MS patients compared with controls (p=0.019). CSF UA concentrations were lower in MS patients as compared to controls, as well as in patients with active MS (clinical and/or MRI activity) in comparison to patients with inactive MS or controls, but these differences were not statistically significant. Significant correlation was found between CSF and serum UA concentrations (p=0.016) in MS patients, but not in controls; and between CSF UA concentrations and the CSF/serum albumin quotient in MS patients (p=0.043), but not in controls. Conclusions: Our results support the significance of UA in the pathogenesis of MS. Decreased serum UA concentrations in MS patients might be due to both intrinsically reduced antioxidant capacity and increased UA consumption in MS. CSF UA concentrations may not be a reliable marker of disease activity in MS since its concentration is dependent on leakage of UA molecules from serum through the damaged BBB and the balance between consumption/production within the central nervous system (CNS). Clin Chem Lab Med 2009; 47: 848-53.
T2  - Clinical Chemistry and Laboratory Medicine
T1  - Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis
IS  - 7
VL  - 47
EP  - 853
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_1442
ER  - 

@article{
author = "Dujmović, Irena and Pekmezović, Tatjana D and Obrenović, Radmila Z and Nikolić, Aleksandra L. and Spasić, Mihajlo and Mostarica-Stojković, Marija B and Drulović, Jelena S",
year = "2009",
abstract = "Background: Peroxynitrite was hypothesized to be involved in the pathogenesis of multiple sclerosis (MS) through its various neurotoxic effects. Uric acid (UA) was shown to be a strong peroxynitrite scavenger. Methods: We analyzed cerebrospinal fluid (CSF) and serum UA concentrations in 30 MS patients and 20 controls with non-inflammatory neurological diseases (NIND) and correlated these findings with demographic and clinical characteristics of MS patients. Disease activity was assessed by brain magnetic resonance imaging (MRI) and the CSF/serum albumin quotient as an indicator of the state of blood-brain-barrier (BBB). Results: Serum UA concentrations were found to be significantly lower in MS patients compared with controls (p=0.019). CSF UA concentrations were lower in MS patients as compared to controls, as well as in patients with active MS (clinical and/or MRI activity) in comparison to patients with inactive MS or controls, but these differences were not statistically significant. Significant correlation was found between CSF and serum UA concentrations (p=0.016) in MS patients, but not in controls; and between CSF UA concentrations and the CSF/serum albumin quotient in MS patients (p=0.043), but not in controls. Conclusions: Our results support the significance of UA in the pathogenesis of MS. Decreased serum UA concentrations in MS patients might be due to both intrinsically reduced antioxidant capacity and increased UA consumption in MS. CSF UA concentrations may not be a reliable marker of disease activity in MS since its concentration is dependent on leakage of UA molecules from serum through the damaged BBB and the balance between consumption/production within the central nervous system (CNS). Clin Chem Lab Med 2009; 47: 848-53.",
journal = "Clinical Chemistry and Laboratory Medicine",
title = "Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis",
number = "7",
volume = "47",
pages = "853",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_1442"
}

Dujmović, I., Pekmezović, T. D., Obrenović, R. Z., Nikolić, A. L., Spasić, M., Mostarica-Stojković, M. B.,& Drulović, J. S.. (2009). Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis. in Clinical Chemistry and Laboratory Medicine, 47(7).
https://hdl.handle.net/21.15107/rcub_ibiss_1442

Dujmović I, Pekmezović TD, Obrenović RZ, Nikolić AL, Spasić M, Mostarica-Stojković MB, Drulović JS. Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis. in Clinical Chemistry and Laboratory Medicine. 2009;47(7):null-853.
https://hdl.handle.net/21.15107/rcub_ibiss_1442 .

Dujmović, Irena, Pekmezović, Tatjana D, Obrenović, Radmila Z, Nikolić, Aleksandra L., Spasić, Mihajlo, Mostarica-Stojković, Marija B, Drulović, Jelena S, "Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis" in Clinical Chemistry and Laboratory Medicine, 47, no. 7 (2009),
https://hdl.handle.net/21.15107/rcub_ibiss_1442 .